Key Highlights
- Ed Tekeian appointed as Senior Vice President of Engineering at Cellino Biotech, Inc., enhancing the company’s focus on building a scalable biomanufacturing platform.
- Tekeian’s vast experience spans over 30 years in product development, including SaaS applications for 3D printers and an FDA-approved intraoral scanner.
- Matthias Wagner, Co-Founder & CTO of Cellino, emphasizes the importance of Tekeian’s multidisciplinary engineering leadership in enabling wide access to regenerative therapies.
Source: Business Wire
Notable Quotes
- “We are thrilled to welcome Ed, who will bring deep multidisciplinary engineering leadership experience…” – Matthias Wagner, Co-Founder & CTO at Cellino Biotech
- “Cellino is harnessing multiple technologies to make patient-specific cells accessible to everyone. I’m honored to be joining such an impressive team.” – Ed Tekeian, Senior Vice President of Engineering at Cellino Biotech
SoHC's Take
The addition of Ed Tekeian to Cellino Biotech’s executive leadership marks a pivotal step forward for the company and the field of regenerative medicine. Tekeian’s broad experience in engineering and product development across various healthcare technologies will significantly contribute to Cellino’s mission to create a scalable biomanufacturing platform. This advancement not only underscores the company’s commitment to innovation but also highlights the growing importance of regenerative medicine in addressing patient-specific needs. As the industry continues to evolve, Tekeian’s leadership could steer Cellino Biotech towards realizing its vision of making personalized human cells accessible worldwide, thereby transforming the landscape of healthcare and patient treatment.
